Skip to content

Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.

Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01971307
Acronym
SGE-PsyScan
Enrollment
336
Registered
2013-10-29
Start date
2013-12-31
Completion date
2015-09-30
Last updated
2015-12-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorders

Brief summary

Although effective treatments for psychosocial symptoms and disorders are available, patients frequently do not receive the most appropriate and effective treatment for their symptoms because of inappropriate and unstructured diagnostics of psychosocial symptoms in general practice. The hypothesis is that by using the intervention SGE-PsyScan the clinical symptoms of patients can be assessed more uniformly and earlier as opposed to the GPs' assessment in usual care. As a result, patients are supposed to start earlier with a treatment that fits the type and severity of their symptoms better. The patients will be randomly assigned to either receive the SGE-PsyScan or usual care.

Interventions

OTHERSGE-PsyScan

Sponsors

Stichting Gezondheidscentra Eindhoven (SGE)
CollaboratorUNKNOWN
Stichting Volksgezondheidszorg (VGZ)
CollaboratorUNKNOWN
Zorgverzekeraar CZ
CollaboratorOTHER
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with (suspected) psychosocial symptoms * Aged 18 years or older and capacitated * Adequate understanding of Dutch language * Able to perform SGE-PsyScan at home, individually

Exclusion criteria

* Clear and treatable somatic causes of symptoms * Acute distress/danger * No written informed consent

Design outcomes

Primary

MeasureTime frame
The rate of patients who achieve a successful decrease in the level of psychosocial symptoms as measured with the Symptom Checklist 90 (SCL-90) after 12 months. A successful treatment result is defined as a decrease in the SCL-90 patient score of 50%.12 months

Secondary

MeasureTime frameDescription
The level of psychosocial symptoms of patients as measured with the SCL-903 months
Health technology assessment3 monthsWe will measure direct and indirect costs in both groups with the Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness (TiC-P) and Electronic Medical Records (EMR) parameters indicating relevant expenditures including treatments, consultations and referrals
The extent of patient satisfaction with the care they receive, will be measured using the Patient Assessment of Chronic Illness Care (PACIC)3 months
Electronic medical records parameters12 monthsRelevant psychosocial care parameters will be extracted from the EMR to monitor changes in care patterns including previous psychosocial episodes, numbers and types of psychosocial diagnoses, use of screening/diagnostic instruments, comorbidity, treatments, medication prescriptions, referrals and health care consumption.
Quality of life will be measured using the EuroQol-5Dimensions-5Levels (EQ-5D-5L) questionnaire3 months

Other

MeasureTime frame
Health care provider satisfaction with the Assessment of Chronic Illness Care (ACIC)12 months

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026